Recent Quotes (30 days)

You have no recent quotes
chg | %

Angiotech Pharmaceuticals, Inc.  

(Public, TSE:ANP)   Watch this stock  
Find more results for ANP
Apr 9 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.55 - 3.10
Open     -
Vol / Avg. 0.00/115,000.00
Mkt cap 96.23M
P/E     -
Div/yield     -
EPS -0.27
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '11) 2010
Net profit margin 653.56% -27.13%
Operating margin 661.96% -11.79%
EBITD margin - 8.88%
Return on average assets 322.70% -19.76%
Return on average equity - -
CDP Score - -


1618 Station Street
+1-604-2217676 (Phone)
+1-604-2212330 (Fax)

Website links


Angiotech Pharmaceuticals, Inc., through its subsidiary, Surgical Specialties Corporation, is engaged in provision of private label and original equipment manufacturer (OEM) medical devices for surgery, wound closure, ophthalmology and radiology. The Company offers a portfolio of blades and sutures, such as the Quill Knotless Tissue-Closure Device and Biosentry Tract Sealant System. Its products are used in dental surgery, dermatology, electrophysiology, gynecology, laparoscopic surgery, microsurgery, ophthalmic surgery, orthopedic surgery, plastic surgery, urology and veterinary medicine. It also specializes in the design and manufacturing of surgical knives products. It also offers design assistance for new sutures, single-use disposable knives and other medical device-related products, as well as assembly services. The Company manufactures LOOK sutures and Sharpoint ophthalmic microsurgical knives and sutures. The Company has operations in Latin America, Europe and China.